UG Healthcare Corporation Limited

SGX:8K7.SI

0.13 (SGD) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SGD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 49.69745.23455.899115.32117.278178.984159.41791.03126.87626.30226.62823.68821.05120.34422.15119.36118.28318.26516.70217.57815.30415.65613.63215.049
Cost of Revenue 41.58249.92149.76475.48472.72882.05260.18958.27522.08921.32621.33318.93216.81815.91218.92616.04615.02715.29614.7714.29513.07613.43311.50311.695
Gross Profit 8.115-4.6876.13539.83644.5596.93299.22832.7564.7874.9765.2954.7564.2334.4323.2253.3153.2562.9691.9323.2832.2282.2232.1293.354
Gross Profit Ratio 0.163-0.1040.110.3450.380.5420.6220.360.1780.1890.1990.2010.2010.2180.1460.1710.1780.1630.1160.1870.1460.1420.1560.223
Reseach & Development Expenses 000000000000000000000000
General & Administrative Expenses 000000003.2673.1083.7793.1862.7382.5672.5362.1422.191.8611.4632.0731.4681.6722.1911.138
Selling & Marketing Expenses 000000000.8040.7640.9140.7810.6160.5040.440.6220.3990.4630.460.4520.3570.4150.0570.586
SG&A 14.1913.01913.54816.68516.53523.28817.0869.7754.0713.8724.6933.9673.3543.0712.9762.7642.5892.3241.9232.5251.8252.0872.2481.724
Other Expenses 000000000.673-0.894-1.6090.252-0.214-0.079-2.7150.655-0.027-0.03-0.042-0.419-0.013-0.1450.696-1.257
Operating Expenses 14.1913.01913.54816.68516.53523.28817.0869.7754.0713.8724.6933.9673.3543.0712.9762.7642.0521.8671.5152.1281.4531.421.2680.334
Operating Income -6.075-17.706-7.41323.15128.01573.64482.14222.9811.4180.4360.8391.2640.7611.5171.7731.461.2041.1020.4171.1550.7750.8030.8613.02
Operating Income Ratio -0.122-0.391-0.1330.2010.2390.4110.5150.2520.0530.0170.0320.0530.0360.0750.080.0750.0660.060.0250.0660.0510.0510.0630.201
Total Other Income Expenses Net 0-1.659-2.14-0.927-1.5771.931-1.893-6.671-0.502-0.506-0.386-0.463-0.408-0.362-0.244-0.216-0.023-0.009-0.18-0.271-0.083-0.0481.061-1.33
Income Before Tax -6.075-19.365-9.55322.22426.43875.57580.24916.310.916-0.070.4530.8010.3531.1551.5291.2441.1811.0930.2370.8840.6920.7551.9221.69
Income Before Tax Ratio -0.122-0.428-0.1710.1930.2250.4220.5030.1790.034-0.0030.0170.0340.0170.0570.0690.0640.0650.060.0140.050.0450.0480.1410.112
Income Tax Expense -0.145-1.014-0.3843.1085.85518.53820.9212.4310.3620.178-0.0760.1820.1230.3160.350.0430.1510.1890.0160.1390.1270.1081.0080.162
Net Income -4.979-15.956-4.77815.54921.24663.82654.93912.5560.5410.3050.5390.6480.2811.0381.3291.1041.0440.8590.1110.9460.5970.7890.5421.675
Net Income Ratio -0.1-0.353-0.0850.1350.1810.3570.3450.1380.020.0120.020.0270.0130.0510.060.0570.0570.0470.0070.0540.0390.050.040.111
EPS -0.008-0.026-0.0080.0250.0350.10.0910.0210.0010.00100.0010.0010.00200.0020.0020.00200.0020.0010.0010.0010.003
EPS Diluted -0.008-0.026-0.0080.0250.0350.10.0910.0210.0010.00100.0010.0010.00200.0020.0020.00200.0020.0010.0010.0010.003
EBITDA -4.308-15.804-5.84125.59429.47875.51783.30424.4261.9380.9341.4311.6361.1421.8922.1131.8571.6741.60.9151.2921.0821.1332.0062.217
EBITDA Ratio -0.087-0.349-0.1040.2220.2510.4220.5230.2680.0720.0360.0540.0690.0540.0930.0950.0960.0920.0880.0550.0740.0710.0720.1470.147